Leukocyte adhesion deficiency-III in an African-American patient

Pediatric Blood and Cancer

Volumn 55, Issue 1, 2010, Pages 180-182

  Sabnis, Himalee ^a   Kirpalani, Anjali ^b   Horan, John ^a   McDowall, Alison ^c   Svensson, Lena ^c   Cooley, Anthony ^b   Merck, Tara ^a   Jobe, Shawn ^a   Hogg, Nancy ^c   Briones, Michael ^a  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Bleeding disorders; Especially newborn; KINDLIN; Leukocyte adhesion deficiency; Neutrophil function; Non malignant condition BMT; Platelet aggregation

Indexed keywords

BETA2 INTEGRIN; BUSULFAN; CD18 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUDARABINE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; THYMOCYTE ANTIBODY;

AFRICAN AMERICAN; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BLEEDING; CASE REPORT; DRUG DOSE REDUCTION; ERYTHROCYTE TRANSFUSION; ESCHERICHIA COLI; FEMALE; GENE MUTATION; GRAFT VERSUS HOST REACTION; HUMAN; INFANT; KINDLIN 3 GENE; LEUKOCYTE ADHESION DEFICIENCY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SEPSIS; THROMBOCYTE TRANSFUSION; UROSEPSIS;

BONE MARROW TRANSPLANTATION; FEMALE; HUMANS; INFANT, NEWBORN; LEUKOCYTE-ADHESION DEFICIENCY SYNDROME; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 77953274923     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22386     Document Type: Article

References (21)

1. Alon R, Etzioni A. LAD-III, a novel group of leukocyte integrin activation deficiencies. Trends Immunol 2003;24:561-566. (Pubitemid 37205208)
2. Harris ES, McIntyre TM, Prescott SM, et al. The leukocyte integrins. J Biol Chem 2000;275:23409-23412.
3. Coller BS, Shattil SJ. The GPIIb/IIIa (integrin alphaIIbbeta3) odyssey: A technology-driven saga of a receptor with twists, turns, and even a bend. Blood 2008;112:3011-3025.
4. Anderson DC, Springer TA. Leukocyte adhesion deficiency: An inherited defect in the Mac-1, LFA-1, and p150,95 glycoproteins. Annu Rev Med 1987;38:175-194.
5. Hogg N, Bates PA. Genetic analysis of integrin function in man: LAD-1 and other syndromes. Matrix Biol 2000;19:211-222. (Pubitemid 30601754)
6. Alon R, Aker M, Feigelson S, et al. A novel genetic leukocyte adhesion deficiency in subsecond triggering of integrin avidity by endothelial chemokines results in impaired leukocyte arrest on vascular endothelium under shear flow. Blood 2003;101:4437-4445. (Pubitemid 36857810)
7. Harris ES, Shigeoka AO, Li W, et al. A novel syndrome of variant leukocyte adhesion deficiency involving defects in adhesion mediated by beta1 and beta2 integrins. Blood 2001;97:767-776.
8. Kuijpers TW, van Bruggen R, Kamerbeek N, et al. Natural history and early diagnosis of LAD-1/variant syndrome. Blood 2007; 109:3529-3537. (Pubitemid 46572546)
9. Kuijpers TW, Van Lier RA, Hamann D, et al. Leukocyte adhesion deficiency type 1 (LAD-1)/variant. A novel immunodeficiency syndrome characterized by dysfunctional beta2 integrins. J Clin Invest 1997;100:1725-1733. (Pubitemid 27431328)
10. McDowall A, Inwald D, Leitinger B, et al. A novel form of integrin dysfunction involving beta1, beta2, and beta3 integrins. J Clin Invest 2003;111:51-60. (Pubitemid 36134848)
11. Pasvolsky R, Feigelson SW, Kilic SS, et al. A LAD-III syndrome is associated with defective expression of the Rap-1 activator CalDAG-GEFI in lymphocytes, neutrophils, and platelets. J Exp Med 2007;204:1571-1582.
12. Kuijpers TW, van de Vijver E,Weterman MA, et al. LAD-1/variant syndrome is caused by mutations in FERMT3. Blood 2009;113: 4740-4746.
13. Malinin NL, Zhang L, Choi J, et al.Apoint mutation in KINDLIN3 ablates activation of three integrin subfamilies in humans. Nat Med 2009;15:313-318.
14. Mory A, Feigelson SW, Yarali N, et al. Kindlin-3: A new gene involved in the pathogenesis of LAD-III. Blood 2008;112: 2591.
15. Svensson L, Howarth K, McDowall A, et al. Leukocyte adhesion deficiency-III is caused by mutations in KINDLIN3 affecting integrin activation. Nat Med 2009;15:306-312.
16. Moser M, Nieswandt B, Ussar S, et al. Kindlin-3 is essential for integrin activation and platelet aggregation. Nat Med 2008;14: 325-330. (Pubitemid 351347914)
17. Moser M, Legate KR, Zent R, et al. The tail of integrins, talin, and kindlins. Science 2009;324:895-899.
18. Evans R, Patzak I, Svensson L, et al. Integrins in immunity. J Cell Sci 2009;122:215-225.
19. Han J, Lim CJ, Watanabe N, et al. Reconstructing and deconstructing agonist-induced activation of integrin alphaIIbbeta3. Curr Biol 2006;16:1796-1806.
20. Qasim W, Cavazzana-Calvo M, Davies EG, et al. Allogeneic hematopoietic stem-cell transplantation for leukocyte adhesion deficiency. Pediatrics 2009;123:836-840.
21. McDowell A, Svensson L, Stanley P, Patzak I, Chakravarty P, Howarth K, Sabnis H, Briones M, Hogg, N. Two mutations in KINDLIN-3 gene of a new Leukocyte Adhesion Deficiency-III patient reveal distinct effects on leukocyte function in vitro. Blood (under revision).